Companies/US/ARDX

ARDELYX, INC.

Last · —$3.19+0.07 (+2.24%)live · yahoo · 1s ago
Vol 5.82M ≈ 18.57M
Market cap$823.62M—
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session

Issuer

Legal nameARDELYX, INC.
HQUnited States (US)
ListingUS ARDX
ISINUS0396971071
SectorHealthcare
IndustryDrugs (Pharmaceutical)
SIC2834
CurrencyUSD
Entity registrysec:0001437402
CIK0001437402
Employees489
AddressArdelyx, Inc. 400 5th Avenue 02451, Waltham +510 745 1700
Headline financial metrics
Revenue$450.9M
Operating income$-35.5M
Net income$-54.3M
Free cash flow$-38.7M
Operating margin-7.9%
Net margin-12.0%
Return on equity-36.5%
PeriodTTM 2026-06-30
Loading chart…

OpenFilings analyst

Our analyst

10-K · 2026-02-19

From latest 10-K · 2026-02-19

  • Operating Cf Burn
  • Net Margin Sharply Negative
  • Cash Conversion Weak
  • Cash Runway Low
  • Accumulated Deficit High

Red flags

  • Operating Cf Burn — Negative operating cash flow
  • Net Margin Sharply Negative — Net margin -15.1%
  • Cash Conversion Weak — Cash conversion (CFO/Rev) -10.4%
  • Cash Runway Low — Cash runway ~1.6 years
  • Accumulated Deficit High — Accumulated deficit / equity 567%

Upcoming earnings

1 event
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.02
Est. revenue
129.0M

Earnings transcripts

1 recent

Documents

FormReporting forFiledFlags
2026-08-112026-08-170
2026-06-302026-08-06 5
2026-07-152026-07-170